Compare · EW vs MTRN
EW vs MTRN
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Materion Corporation (MTRN): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while MTRN operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $51.87B, about 9.8x MTRN ($5.27B).
- Over the past year, EW is up 17.3% and MTRN is up 197.9% - MTRN leads by 180.7 points.
- EW has been more active in the news (6 items in the past 4 weeks vs 2 for MTRN).
- EW has more recent analyst coverage (25 ratings vs 10 for MTRN).
- Company
- Edwards Lifesciences Corporation
- Materion Corporation
- Price
- $90.07-1.89%
- $253.21+2.49%
- Market cap
- $51.87B
- $5.27B
- 1M return
- +5.04%
- +2.77%
- 1Y return
- +17.26%
- +197.92%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 2
- Recent ratings
- 25
- 10
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Materion Corporation
Materion Corporation manufactures and sells advanced engineered materials used in semiconductor, industrial, aerospace and defense, automotive, energy, consumer electronics, and telecom and data center markets in the United States, Asia, Europe, and internationally. It operates through Performance Alloys and Composites, Advanced Materials, and Precision Optics segments. The Performance Alloys and Composites segment provides copper and nickel products in plate, rod, bar, tube, strip, wire product forms, as well as other customized shapes; precision strip products; beryllium hydroxide; and beryllium products, such as beryllium composites, ceramics, and engineered clad and plated metal systems, as well as aluminum silicon carbide metal matrix. This segment also produces strip metal products with clad inlay and overlay metals consisting of precious and base metal electroplated systems, electron beam welded systems, contour profiled systems, and solder-coated metal systems. The Advanced Materials segment provides advanced chemicals, microelectronics packaging, precious and non-precious metals, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms, high temperature braze materials, and ultra-pure wires. The Precision Optics segment produces sputter-coated precision thin film coatings and optical filter materials. It distributes its products through company-owned facilities, and independent distributors and agents. The company was formerly known as Brush Engineered Materials Inc. and changed its name to Materion Corporation in 2011. Materion Corporation was incorporated in 1931 and is headquartered in Mayfield Heights, Ohio.
Latest EW
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)
- Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
- CEO Zovighian Bernard J sold $45,982 worth of shares (523 units at $87.92) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 11-K filed by Edwards Lifesciences Corporation
- SEC Form 11-K filed by Edwards Lifesciences Corporation
- SEC Form 3 filed by new insider Mistras Theodora
Latest MTRN
- Materion Corporation to Participate in CJS Securities’ 26th Annual Summer Conference on July 9
- SEC Form 11-K filed by Materion Corporation
- SEC Form 4 filed by Vice President, Finance & CFO Chadwick Shelly Marie
- SEC Form 4 filed by Chief Accounting Officer Fashinpaur Melissa A
- Director Liggett Emily M was granted 1 shares (SEC Form 4)
- Director Prevost Patrick M. was granted 9 shares (SEC Form 4)
- SEC Form 4 filed by President and CEO Vijayvargiya Jugal K.
- SEC Form 4 filed by VP General Counsel & Secretary Chemnitz Gregory R.
- Director Phillippy Robert J was granted 7 shares (SEC Form 4)
- Director Shular Craig S was granted 31 shares (SEC Form 4)